AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.31X leverage
Performance
- Low
- ₹440
- High
- ₹448
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹446
- Previous Close₹448
- Volume38,687
- 50 DMA₹440.23
- 100 DMA₹451.29
- 200 DMA₹494.83
Investment Returns
- Over 1 Month + 0.47%
- Over 3 Month -2.92%
- Over 6 Month -8.24%
- Over 1 Year -22.2%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22.2
- PEG Ratio
- 1.6
- Market Cap Cr
- 7,034
- P/B Ratio
- 2.2
- Average True Range
- 12.77
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- 0.43
- RSI
- 56.68
- MFI
- 60.58
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹446.90
-0.75
(-0.17%)
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹440.30
- 50 Day
- ₹440.23
- 100 Day
- ₹451.29
- 200 Day
- ₹494.83
Resistance and Support
444.97
- R3 457.93
- R2 452.97
- R1 449.93
- S1 441.93
- S2 436.97
- S3 433.93
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹446 As on 07 February, 2026 | 16:52
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7033.9 Cr As on 07 February, 2026 | 16:52
The P/E ratio of Akums Drugs & Pharmaceuticals is 22.2 As on 07 February, 2026 | 16:52
The PB ratio of Akums Drugs & Pharmaceuticals is 2.2 As on 07 February, 2026 | 16:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.